The FDA just approved a new drug which can slow progression of early symptoms. A couple in Kensington said this drug is ...
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease. It's only the second drug that ...
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
The Federal Drug Administration gave the go-ahead to a second Alzheimer’s treatment Tuesday after a study suggested that it ...
Alzheimer's disease affects millions of Americans as well as their families as they learn to live with their loved one ...
It’s a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial ...
Eli Lilly received FDA approval for a drug to help treat Alzheimer's on Tuesday after studies showed it could help slow the ...
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
The U.S. Food and Drug Administration on Tuesday gave a green light to Eli Lilly's donanemab for patients with early ...
The FDA approved Eli Lilly's drug Kisunla to treat early-stage Alzheimer's disease. Kisunla is only the second drug approved ...
The Food and Drug Administration on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company announced, clearing the way ...